These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32079793)

  • 1. New Treatment for Partial-Onset Seizures in Adults.
    Aschenbrenner DS
    Am J Nurs; 2020 Mar; 120(3):24-25. PubMed ID: 32079793
    [No Abstract]   [Full Text] [Related]  

  • 2. Cenobamate tablets as a treatment for focal-onset seizures in adults.
    Steinhoff BJ
    Expert Rev Clin Pharmacol; 2021 Feb; 14(2):161-172. PubMed ID: 33470139
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug-Drug Interactions and Tolerability.
    Roberti R; De Caro C; Iannone LF; Zaccara G; Lattanzi S; Russo E
    CNS Drugs; 2021 Jun; 35(6):609-618. PubMed ID: 33993416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cenobamate for the treatment of focal epilepsies.
    Strzelczyk A; Mann C; Willems LM; Rosenow F; Bauer S
    Expert Opin Pharmacother; 2020 Dec; 21(18):2215-2223. PubMed ID: 32812825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cenobamate (Xcopri) for focal seizures.
    Med Lett Drugs Ther; 2020 Aug; 62(1605):134-136. PubMed ID: 32970044
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending-Dose Studies in Healthy Subjects.
    Vernillet L; Greene SA; Kamin M
    Clin Pharmacol Drug Dev; 2020 May; 9(4):428-443. PubMed ID: 32087001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of cenobamate in patients with uncontrolled focal seizures: A meta-analysis.
    Zhang L; Wang J; Wang C
    Acta Neurol Scand; 2021 Jul; 144(1):58-66. PubMed ID: 33788253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive cenobamate for the treatment of focal onset seizures in adults with epilepsy: a critical review.
    Wheless JW
    Expert Rev Neurother; 2020 Nov; 20(11):1085-1098. PubMed ID: 33031714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures.
    Halford JJ; Ben-Menachem E; Kwan P; Ness S; Schmitt J; Eerdekens M; Novak G
    Epilepsia; 2011 Apr; 52(4):816-25. PubMed ID: 21320109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cenobamate for the treatment of focal epilepsy.
    Dhir A
    Drugs Today (Barc); 2020 Apr; 56(4):233-240. PubMed ID: 32309819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cenobamate: First Approval.
    Keam SJ
    Drugs; 2020 Jan; 80(1):73-78. PubMed ID: 31933170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ezogabine (Potiga) for epilepsy.
    Med Lett Drugs Ther; 2012 Aug; 54(1397):65-7. PubMed ID: 22907178
    [No Abstract]   [Full Text] [Related]  

  • 13. Ezogabine (Potiga) toxicity.
    Med Lett Drugs Ther; 2013 Nov; 55(1430):96. PubMed ID: 24276503
    [No Abstract]   [Full Text] [Related]  

  • 14. New epilepsy treatment receives FDA approval.
    Lavine G
    Am J Health Syst Pharm; 2008 Dec; 65(24):2310. PubMed ID: 19052267
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies.
    Gil-Nagel A; Brodie MJ; Leroy R; Cyr T; Hall S; Castiglia M; Twomey C; VanLandingham K
    Epilepsy Res; 2012 Nov; 102(1-2):117-21. PubMed ID: 22771137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine approved for partial seizures.
    Miller JL
    Am J Health Syst Pharm; 2000 Mar; 57(5):414, 417. PubMed ID: 10711517
    [No Abstract]   [Full Text] [Related]  

  • 17. Ezogabine: an evaluation of its efficacy and safety as adjunctive therapy for partial-onset seizures in adults.
    Yamada M; Welty TE
    Ann Pharmacother; 2012 Oct; 46(10):1358-67. PubMed ID: 22991134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures.
    Lerche H; Daniluk J; Lotay N; DeRossett S; Edwards S; Brandt C
    Seizure; 2015 Aug; 30():93-100. PubMed ID: 26216692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass Balance, Metabolism, and Excretion of Cenobamate, a New Antiepileptic Drug, After a Single Oral Administration in Healthy Male Subjects.
    Vernillet L; Greene SA; Kim HW; Melnick SM; Glenn K
    Eur J Drug Metab Pharmacokinet; 2020 Aug; 45(4):513-522. PubMed ID: 32301064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
    Tompson DJ; Crean CS; Reeve R; Berry NS
    Clin Ther; 2013 Aug; 35(8):1174-1185.e4. PubMed ID: 23916044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.